1. Home
  2. Browse Decisions
  3. F.Supp.2d
  4. 381 F.Supp.2d
  5. 381 F.Supp.2d 1378 (2005)
 

IN RE SUMATRIPTAN SUCCINATE PATENT LITIGATION

No. 1701.

381 F.Supp.2d 1378 (2005)

IN RE SUMATRIPTAN SUCCINATE PATENT LITIGATION Glaxo Group, Ltd. v. Spectrum Pharmaceuticals, Inc., D. Delaware, C.A. No. 1:05-99 Glaxo Group, Ltd. v. Dr. Reddy's Laboratories, Ltd., et al., S.D. New York, C.A. No. 1:03-10260 Glaxo Group, Ltd. v. Cobalt Pharmaceuticals, Inc., S.D. New York, C.A. No. 1:04-9886

Judicial Panel on Multidistrict Litigation.

August 9, 2005.

ORDER DENYING TRANSFER

WM. TERRELL HODGES, Chairman.

This litigation consists of two now consolidated Southern District of New York actions and one District of Delaware action. Each MDL-1701 action is brought by patent owner Glaxo Group Ltd. (Glaxo) for infringement of a Glaxo patent that claims sumatriptan succinate, the active ingredient in Glaxo's Imitrex(R) products, which are prescribed for treatment of migraine. Plaintiff Glaxo moves for centralization...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases